Press Releases

Health News Posted on Monday, February 23, 2015

Premium Press Releases »

Europes Main Computational Biology Conference Comes to Turku, Finland

Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...

Read More

Press Releases »

Weight Loss and Weight Management Market Worth $206.4 Billion by 2019

DALLAS , February 23, 2015 /PRNewswire/ -- According to a new market research report " Weight Loss and Weight Management Market by Equipment (Fitness Equipment (Treadmill, Stair Steppers)), Surgical Equipment (Adjustable Gastric Band, Gastric ...

Read More

AIDSVu Unveils First Site to Map the HIV Care Continuum

HIVContinuum.org Visualizes the HIV Treatment Cascade in Five Heavily Impacted U.S. Cities to Help Address Health Disparities ATLANTA , Feb. 23, 2015 /PRNewswire-USNewswire/ -- Today, AIDSVu launched HIVContinuum.org, a site that ...

Read More

World Pre-Clinical Imaging Market Growing at 15% CAGR to 2019

DALLAS , February 23, 2015 /PRNewswire/ -- Global Preclinical Imaging Market 2015-2019 and Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents with Global Forecasts to 2019 are the new 2015 diagnostics market research reports now ...

Read More

Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) Published Online in JAMA; Sub-analyses to be Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI)

- In adult patients co-infected with genotype 1 (GT1) hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1), TURQUOISE-I, using VIEKIRA PAK with ribavirin (RBV), demonstrated sustained virologic response rates 12 weeks ...

Read More

Michael J. Fox Foundation Analysis Reveals Gaps between Research Volunteers and Parkinson's Clinical Studies

Baseline paper highlights findings from Fox Trial Finder, first smart-matching clinical research recruitment tool for Parkinson's disease NEW YORK , Feb. 23, 2015 /PRNewswire-USNewswire/ -- A paper authored by The Michael J. Fox Foundation ...

Read More

Affordable Care Act -- Credit or Penalty?

MEDFORD, Ore. , Feb. 23, 2015 /PRNewswire/ -- With the introduction of the Affordable Care Act (or Obamacare) will you have a credit or a penalty on your tax return this year? Will you have a credit? This credit is called the Premium Tax ...

Read More

Take Control of Your Life Today with "Supercharge Your Emotions to Win: 7 Keys to Achieve the Life You Desire & Deserve" by Benjamin Halpern

LAKEWOOD, N.J. , Feb. 23, 2015 /PRNewswire/ -- In his new book, "Supercharge Your Emotions to Win: 7 Keys to Achieve the Life You Desire & Deserve," personal development expert Benjamin Halpern shows readers how to develop and attach ...

Read More

Savara Pharmaceuticals' AeroVanc Meets Primary Endpoint of MRSA Reduction in Phase 2 Trial in People with Cystic Fibrosis

Trial also demonstrates strong trends in secondary clinical endpoints AUSTIN, Texas , Feb. 23, 2015 /PRNewswire/ -- Savara Pharmaceuticals announced today positive topline results from its Phase 2 clinical trial of AeroVanc, the first ...

Read More

Intas Pharmaceuticals Becomes the First Indian Company to Launch a Biosimilar in the EU

AHMEDABAD, India , February 23, 2015 /PRNewswire/ -- Intas becomes the first Indian company to launch a biosimilar in highly regulated markets like EU, US and Japan . The company today announced that they have launched their first biosimilar, ...

Read More

Experimenting Preteens May Have Different Brain Processes

MINNEAPOLIS , Feb. 23, 2015 /PRNewswire-USNewswire/ -- Preteens who experiment or explore new things may have brain processes that work differently than those of preteens who do not, according to a study released today that will be presented at ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.